We established an ischemia-reperfusion model through in vivo and in vitro experiments to confirm that ALR can regulate necroptosis through the RIP1/RIP3/MLKL pathway, thereby alleviating acute kidney injury. The gene discussed is MLKL; the disease is acute kidney injury.